DOWNERS
GROVE, Ill., Sept. 11,
2024 /PRNewswire/ -- CPC (Colder Products Company),
part of Dover (NYSE: DOV) and a leading manufacturer of
connection technologies used in biopharmaceutical processing, today
announced the launch of a new aseptic micro-connector that fits
directly into the freeze cassettes used in cell and gene therapy
(CGT) processing.
Cryopreservation – freezing CGT biological materials at ultralow
temperatures – helps minimize material loss of function during
product shipment and storage, which occur before therapies are
delivered to patients.
"To support cell health, shelf life, and transportation needs,
many cell therapy processes are dropping to -150ºC or lower
temperature ranges," said Troy
Ostreng, Senior Product Manager for CPC's biopharmaceutical
business. "The new MicroCNX® ULT Series is the
first to conveniently support sterility throughout CGT development
processes by both withstanding temperatures to -190°C and being
compact enough to conveniently fit into a CGT freeze cassette."
MicroCNX ULT connectors provide a simple, efficient method for
sterile connection of tubing used for small-format cell therapy and
gene therapy assemblies. The connectors are also chemically
compatible with harsh chemicals used in cryopreservation processes
like dimethyl sulfoxide (DMSO) and the most commonly used tubing
types in CGT development, including polyvinyl chloride (PVC).
This new series builds on CPC's pioneering work in creating
biopharma's smallest connector, the 1/8" MicroCNX Series, which is
the only alternative to tube welding for creating closed
sterile connections at small volumes.
In June, CPC also introduced MicroCNX Luers. Manufacturers that
routinely connect with luers appreciate the flexibility this new
product offers in creating sterile connections outside of a
biosafety cabinet.
"As a leader in aseptic connection technologies, our goal is to
scale with our customers, helping them easily create sterile
connections from the benchtop to commercialization," said Ostreng.
"CPC already has the broadest aseptic connector portfolio. MicroCNX
ULT connectors are just one more example of our continued
innovation to meet the evolving needs of cell therapy, gene
therapy, and biopharma manufacturers across the globe," he
added.
For more information about the performance and versatility of
the MicroCNX series connectors or any of the other innovative
connection solutions CPC offers, visit cpcworldwide.com/micro.
About CPC:
CPC (Colder Products Company) is the leader in single-use
connection technology, offering a wide variety of connectors for
biopharmaceutical manufacturing. The company's innovative, flexible
products enable users to easily combine multiple components and
systems including process containers, tubing manifolds, transfer
lines, bioreactors and other bioprocess equipment. Robust
single-use connectors maintain media sterility and integrity while
improving production yields, decreasing time to market and reducing
costs. The company's well-known AseptiQuik® connectors
provide quick and easy sterile connections even in non-sterile
environments. Learn more at cpcworldwide.com/bio. Connect
with confidence with CPC, an operating company within Dover
Corporation.
About Dover:
Dover is a diversified global manufacturer and solutions
provider with annual revenue of over $8
billion. We deliver innovative equipment and components,
consumable supplies, aftermarket parts, software and digital
solutions, and support services through five operating segments:
Engineered Products, Clean Energy & Fueling, Imaging &
Identification, Pumps & Process Solutions and Climate &
Sustainability Technologies. Dover combines global scale with
operational agility to lead the markets we serve. Recognized for
our entrepreneurial approach for over 65 years, our team of
approximately 25,000 employees takes an ownership mindset,
collaborating with customers to redefine what's possible.
Headquartered in Downers Grove,
Illinois, Dover trades on the New York Stock Exchange under
"DOV." Additional information is available at
dovercorporation.com.
CPC Contact:
Jana Stender
(612) 564-2053
jana.stender@cpcworldwide.com
Dover Media Contact:
Adrian Sakowicz, VP,
Communications
(630) 743-5039
asakowicz@dovercorp.com
Dover Investor Contact:
Jack
Dickens, Senior Director, Investor Relations
(630) 743-2566
jdickens@dovercorp.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cpc-launches-aseptic-product-for-cell-and-gene-therapy-cryopreservation-302245274.html
SOURCE Dover